In Memory[]
Michael
Patient Information[]
Age: 25
Sex: Male
Diagnosed: September 2005
Relapse: March 2007
Passed Away: September 8, 2008
Location: California
Diagnosis: Stage IV DSRCT. Three large masses in abdomen and possible lymph nodes involvment. One tumor was 10 x 6.
Hospital:
- Kaiser-San Diego, CA
- Indiana University Cancer Center, Indianapolis
- Oncology Consultant/Surgeon: Daniel A. Rushing, MD
Treatment[]
Chemotherapy.
- First Line: P6 Protocol - Cytoxan (Cyclophosphamide); Adriamycin (Doxorubicin); Vincristine;
- Ifosfamide and Etoposide (VP-16);
- Second Line: Combination of Adriamycin (Doxorubicin) and Ifosfamide
Surgery
- Removed the main tumor and a number of smaller nodules in peritoneum. Biopsy revealed tumor necrosis. All visible tumors removed.
Time Line[]
| Date | Test | Treatment | Chemicals | Result |
|---|---|---|---|---|
| 10/05 | 0 | 0 | 0 | 0 |
| 11/05 | 0 | Chemotherapy | P6 | 0 |
| 12/05 | 0 | Chemotherapy | P6 | 0 |
| 1/06 | CT | Chemotherapy | P6 | 45% shrinkage in tumors |
| 2/06 | 0 | Chemotherapy | P6 | 0 |
| 3/06 | 0 | Chemotherapy | P6 | 65% shrinkage |
| 4/06 | 0 | 0 | 0 | 0 |
| 5/06 | 0 | Surgery | 0 | Removed the main tumor and a number of smaller nodules in peritoneum. Biopsy revealed tumor necrosis. All visible tumors removed. |
| 6/06 | 0 | 0 | 0 | 0 |
| 7/06 | 0 | Chemotherapy - 3 more cycles | adriamycin and ifosfamide | 0 |
| 8/06 | 0 | Chemotherapy | 0 | 0 |
| 9/06 | 0 | Chemotherapy | 0 | 0 |
| 10/06 | 0 | 0 | 0 | 0 |
| 11/06 | 0 | 0 | 0 | 0 |
| 12/06 | 0 | 0 | 0 | 0 |
| 1/07 | 0 | 0 | 0 | 0 |
| 2/07 | 0 | 0 | 0 | 0 |
| 3/07 | 0 | 0 | 0 | Relapse. Three new tumors in abdomen and disease in lymph nodes. |
| 4/07 | 0 | Clinical Trial | Phase 1 Clinical Study AMG 479 | 0 |
| 5/07 | 0 | Clinical Trial | Phase 1 Clinical Study AMG 479 | Tumors showed some shrinkage. |
| 6/07 | 0 | Clinical Trial | Phase 1 Clinical Study AMG 479 | 0 |
| 7/07 | CT/PET | Clinical Trial | Phase 1 Clinical Study AMG 479 | Small amount of growth in the spleen mass, no other growth in other tumors, no new tumors. Stable disease. |
| 8/07 | 0 | Clinical Trial | Phase 1 Clinical Study AMG 479 | 0 |
| 9/07 | 0 | Off Clinical Trial | 0 | Progression of disease. Tumors now 30 percent larger than when trial started. |
| 10/07 | 0 | 0 | 0 | 0 |
| 11/07 | 0 | 0 | 0 | 0 |
| 12/07 | 0 | 0 | 0 | 0 |
| 1/08 | 0 | 0 | 0 | 0 |
| 2/08 | 0 | 0 | 0 | 0 |
| 3/08 | 0 | 0 | 0 | 0 |
| 4/08 | 0 | 0 | 0 | 0 |
| 5/08 | 0 | 0 | 0 | 0 |
| 6/08 | 0 | 0 | 0 | 0 |
| 7/08 | 0 | 0 | 0 | 0 |
| 8/08 | 0 | 0 | 0 | 0 |
| 9/8/08 | 0 | 0 | 0 | Passed Away |
[BACK]